Ginkgo Bioworks Holdings (DNABW) Other Non-Current Assets (2020 - 2026)

Ginkgo Bioworks Holdings (DNABW) reported Other Non-Current Assets of $3.2 million for Q1 2026, down 93.14% on a YoY basis from $46.8 million in Q1 2025, and down 93.19% quarter-over-quarter from $47.2 million in Q4 2025.

Ginkgo Bioworks Holdings (DNABW) Other Non-Current Assets (2020 - 2026) Analysis & Trends

Ginkgo Bioworks Holdings has reported Other Non-Current Assets for 7 years, with the latest figure at $3.2 million in Q1 2026.

  • For the quarter ending Q1 2026, Other Non-Current Assets fell 93.14% year-over-year to $3.2 million; the trailing twelve-month figure through Mar 2026 stood at $3.2 million (down 93.14% YoY), and the FY2025 full-year result was $47.2 million, down 14.76% from the prior year.
  • Other Non-Current Assets for Q1 2026 stood at $3.2 million, down from $47.2 million in the prior quarter.
  • The five-year high for Other Non-Current Assets was $97.9 million in Q2 2023, with the low at $3.2 million in Q1 2026.
  • Historically, Other Non-Current Assets has averaged $59.5 million across 5 years, with a median of $55.3 million in 2024.
  • Annual changes were most pronounced in 2023 — Other Non-Current Assets soared 120.87% — and 2026, when it tumbled 93.14%.
  • Ginkgo Bioworks Holdings' Other Non-Current Assets stood at $88.7 million in 2022, then sank by 34.57% to $58.1 million in 2023, then retreated by 4.68% to $55.3 million in 2024, then decreased by 14.76% to $47.2 million in 2025, then slumped by 93.19% to $3.2 million in 2026.
  • The last three Other Non-Current Assets figures came in at $3.2 million (Q1 2026), $47.2 million (Q4 2025), and $46.6 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - 289.41 Mn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 12.40 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 60,000.00
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 1.26 Bn
9 Abivax 91.96 Bn 91.96 Bn - -
10 Ginkgo Bioworks Holdings - - 16.38 Mn 3.21 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 3.21 Mn
Dec 31, 2025 47.17 Mn
Sep 30, 2025 46.59 Mn
Jun 30, 2025 47.02 Mn
Mar 31, 2025 46.78 Mn
Dec 31, 2024 55.34 Mn
Sep 30, 2024 59.79 Mn
Jun 30, 2024 60.21 Mn
Mar 31, 2024 60.63 Mn
Dec 31, 2023 58.06 Mn
Sep 30, 2023 97.02 Mn
Jun 30, 2023 97.95 Mn
Mar 31, 2023 97.26 Mn
Dec 31, 2022 88.73 Mn
Sep 30, 2022 43.93 Mn
Jun 30, 2022 53.02 Mn
Mar 31, 2022 49.62 Mn
Dec 31, 2021 43.99 Mn
Sep 30, 2021 26.80 Mn
Dec 31, 2020 5.60 Mn